Sigma Planning Corp purchased a new position in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 40,330 shares of the company's stock, valued at approximately $1,573,000. Sigma Planning Corp owned approximately 0.12% of The Pennant Group as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new position in The Pennant Group during the second quarter worth $109,340,000. Wasatch Advisors LP grew its position in shares of The Pennant Group by 31.8% in the second quarter. Wasatch Advisors LP now owns 1,870,178 shares of the company's stock valued at $69,103,000 after purchasing an additional 451,491 shares during the period. Paradigm Capital Management Inc. NY acquired a new stake in shares of The Pennant Group in the second quarter valued at about $51,833,000. Turtle Creek Asset Management Inc. grew its position in shares of The Pennant Group by 12,075.6% in the first quarter. Turtle Creek Asset Management Inc. now owns 1,582,823 shares of the company's stock valued at $48,244,000 after purchasing an additional 1,569,823 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in shares of The Pennant Group by 1.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 815,660 shares of the company's stock worth $24,861,000 after purchasing an additional 11,943 shares during the last quarter. Hedge funds and other institutional investors own 85.88% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on the stock. Royal Bank Of Canada raised their price target on shares of The Pennant Group from $42.00 to $44.00 and gave the company an "outperform" rating in a research note on Thursday, August 20th. Wells Fargo & Company boosted their price objective on The Pennant Group from $45.00 to $46.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 11th. Weiss Ratings upgraded The Pennant Group from a "buy (b-)" rating to a "buy (b)" rating in a research note on Wednesday, August 19th. Finally, Truist Financial increased their target price on The Pennant Group from $42.00 to $48.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Five research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $46.00.
Get Our Latest Research Report on The Pennant Group
The Pennant Group Trading Up 1.2%
Shares of PNTG opened at $42.16 on Thursday. The Pennant Group, Inc. has a 52-week low of $22.25 and a 52-week high of $43.10. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.48. The firm's fifty day moving average is $39.84 and its two-hundred day moving average is $35.28. The stock has a market cap of $1.47 billion, a PE ratio of 46.84, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25.
The Pennant Group (NASDAQ:PNTG - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.03. The business had revenue of $297.98 million during the quarter, compared to analyst estimates of $288.71 million. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. Research analysts forecast that The Pennant Group, Inc. will post 1.18 earnings per share for the current fiscal year.
About The Pennant Group
(
Free Report)
The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.
Pennant's home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.
Further Reading
Want to see what other hedge funds are holding PNTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Pennant Group, Inc. (NASDAQ:PNTG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.